Previous studies have shown that SDF-1α can induce BL cell motility, and knockdown of HDAC6 or treatment with HDAC6 inhibitors tubacin and niltubacin can significantly impair SDF-1α-induced cell migration and invasion (Ding et al., 2014). Here, CXCL12 is linked to Burkitt lymphoma.